Zu "1032350-13-2" wurden 4 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
MK-2206 (hydrochloride)
Artikelnummer: Cay11593-1
Three related forms of the kinase Akt (1, 2, 3, also known as protein kinase B isoforms PKBalpha, beta, gamma) modulate cell proliferation, metabolism, and survival as well as angiogenesis. MK-2206 is an orally active, allosteric Akt inhibitor that is equally potent toward purified human recombinant Akt1 and Akt2...
| Schlagworte: | 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naphthyridin-3(2H)-one, dihydrochloride |
| Anwendung: | Allosteric Akt inhibitor |
| CAS | 1032350-13-2 |
| MW: | 480.4 D |
ab 58,00 €
COVID-19 Forschung
MK2206 (dihydrochloride)
Artikelnummer: LKT-M4000.1
MK2206 is a Akt inhibitor, is also an orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non-ATP competitive manner, which may result in the inhibition of...
| Schlagworte: | MK-2206 . 2HCl, 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-8,9-dihydro-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one... |
| Anwendung: | AKT inhibitor |
| CAS | 1032350-13-2 |
| MW: | 445.94 D |
ab 79,00 €
MK-2206
Artikelnummer: SYN-1162-M005
Soluble in DMSO or ethanol. MK-2206 is a highly selective inhibitor of Akt1, Akt2 and Akt3 with IC(50) of 8nM, 12nM and 65nM, respectively. Target: AKT , Kinase Group: AGC , Substrate: Serine-Threonine
| Schlagworte: | MK2206 |
| Anwendung: | AKT inhibitor |
| CAS | 1032350-13-2 |
| MW: | 480,4 D |
ab 92,00 €
COVID-19 Forschung
MK-2206 Dihydrochloride
Artikelnummer: LKT-M400220.100
Akt inhibitor.
| Schlagworte: | MK-2206 hydrochloride |
| Anwendung: | Allosteric Akt inhibitor |
| CAS | 1032350-13-2 |
| MW: | 480.39 D |
ab 76,00 €
